ArticleCureus2025
Carbamazepine-Induced Oral Lichenoid Reaction: A Report of a Rare Case.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Treatments in oral lichen planus: a review.Frontiers in oral health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lichenoid drug reactions (LDRs) are rare adverse effects that resemble lichen planus both clinically and histopathologically. Although cutaneous involvement is more common, oral manifestations are relatively uncommon. Carbamazepine, a widely used antiepileptic drug, has been associated with various cutaneous adverse reactions, but oral lichenoid reactions (OLRs) due to carbamazepine are rarely reported. In this case report, we present a 62-year-old male patient who developed painful white reticular plaques on the buccal mucosa and lateral borders of the tongue after using carbamazepine for approximately 14 months. The lesions completely regressed within three weeks following the discontinuation of the drug. No dental restorations or other possible local irritants were detected. Although histopathological confirmation could not be obtained due to the patient's refusal of a biopsy, the clinical appearance and full remission after drug cessation strongly supported the diagnosis. This case highlights the importance of considering drug-induced OLRs in the differential diagnosis of oral mucosal lesions, especially in patients using medications known to cause lichenoid eruptions. Early recognition and discontinuation of the offending drug are crucial for resolution and patient comfort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.